Published in J Clin Endocrinol Metab on January 01, 1979
Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest (1982) 1.60
Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest (1980) 1.31
Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro. Proc Natl Acad Sci U S A (1982) 1.19
Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci U S A (1986) 1.14
Ectopic acromegaly due to growth hormone releasing hormone. Endocrine (2012) 1.05
Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man. J Clin Invest (1984) 0.93
Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. Am J Pathol (1997) 0.80
Intrasellar hamartoma associated with pituitary adenoma. Acta Neuropathol (1990) 0.75
Levels of human and rat hypothalamic growth hormone-releasing factor as determined by specific radioimmunoassay systems. Proc Natl Acad Sci U S A (1985) 0.75
Recent developments in acromegaly: a review. J R Soc Med (1983) 0.75
Acromegaly update--etiology, diagnosis and management. West J Med (1987) 0.75
Regulation of growth hormone-releasing hormone gene expression and biosynthesis. Yale J Biol Med (1990) 0.75
Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell (1996) 7.69
Comparative ultrastructure of the sinus node in man and dog. Circulation (1966) 2.23
Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution. Exp Hematol (2000) 1.77
Effect of vagotomy and vagal stimulation on insulin secretion. Diabetes (1967) 1.75
Predictors of falls among elderly people. Results of two population-based studies. Arch Intern Med (1989) 1.73
Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial. J Clin Endocrinol Metab (2008) 1.66
Thyroid cancer occurring as a late consequence of head-and-neck irradiation. Evaluation of 1056 patients. N Engl J Med (1976) 1.64
Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases. Hum Pathol (1989) 1.62
Sensitivity in electron microscope autoradiography. I. The effect of radiation dose. J Histochem Cytochem (1972) 1.60
Employee competence and performance-based assessment: A college of American pathologists Q-probes study of larboratory personnel in 522 institutions. Arch Pathol Lab Med (2000) 1.57
Radio-opaque appearance of lanthanum carbonate in a patient with chronic renal failure. Nephrol Dial Transplant (2008) 1.57
Consensus statement: medical management of acromegaly. Eur J Endocrinol (2005) 1.54
Effect of hypothalamic stimulation on plasma glucose, insulin, and glucagon levels. Am J Physiol (1971) 1.47
Randomized controlled trial of ultrasonic dissection versus standard surgical technique in open left hemicolectomy or total gastrectomy. Br J Surg (2011) 1.41
Varicella myocarditis. A case of sudden death. Arch Pathol (1971) 1.35
Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med (1984) 1.35
Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science (1981) 1.33
Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. J Clin Invest (1980) 1.31
The immunofluorescent tumor imprint technique. II. The frequency of antinuclear factors in connective tissue diseases and dermatoses. Ann Intern Med (1966) 1.30
The immunofluorescent "band" test for lupus erythematosus. 3. Employing clinically normal skin. Arch Dermatol (1971) 1.27
Rapid amplification of genomic DNA ends. Biotechniques (1993) 1.19
Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. J Clin Endocrinol Metab (1999) 1.18
Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab (2000) 1.14
Diagnostic accuracy of multiple biopsies from flexible fiberoptic bronchoscopy. A comparison of central versus peripheral carcinoma. Am Rev Respir Dis (1982) 1.11
IL-16 inhibition of CD3-dependent lymphocyte activation and proliferation. J Immunol (1996) 1.10
Diabetes in the Seneca Indians. Plasma insulin responses to oral carbohydrate. Diabetes (1969) 1.08
Thioflavin-T for amyloid detection. Am J Clin Pathol (1967) 1.08
CD4 ligand IL-16 inhibits the mixed lymphocyte reaction. J Immunol (1996) 1.08
Studies of growth hormone secretion in children: normal, hypopituitary and constitutionally delayed. J Clin Endocrinol Metab (1967) 1.06
Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab (1989) 1.05
Cardiac myxoma. A morphologic and histogenetic appraisal. Cancer (1968) 1.05
Predictors of recurrence and survival of patients with breast cancer. Am J Clin Pathol (1987) 1.04
Early human myocardial infarction. A histochemical study. Arch Pathol (1966) 1.04
Growth hormone and insulin levels in weanling rats with ventromedial hypothalamic lesions. Endocrinology (1968) 1.02
A new familial syndrome characterized by pigmentary retinopathy, hypogonadism, mental retardation, nerve deafness and glucose intolerance. Am J Med (1976) 1.00
Growth hormone-releasing hormone. Endocr Rev (1986) 1.00
Effects of antagonists of growth hormone-releasing hormone (GHRH) on GH and insulin-like growth factor I levels in transgenic mice overexpressing the human GHRH gene, an animal model of acromegaly. Endocrinology (1997) 0.99
Receptor-associated resistance to growth hormone-releasing factor in dwarf "little" mice. Science (1986) 0.98
Progesterone receptors as neuroendocrine integrators. Front Neuroendocrinol (2001) 0.98
Central nervous system-mediated stimulation of glucagon secretion in the dog following 2-deoxyglucose. Metabolism (1976) 0.98
Colon cancer and polyps in acromegaly: increased risk associated with family history of colon cancer. Clin Endocrinol (Oxf) (1990) 0.97
Metabolic clearance and production rates of human growth hormone in subjects with normal and abnormal growth. J Clin Endocrinol Metab (1970) 0.97
Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab (1993) 0.97
Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor. J Clin Endocrinol Metab (1988) 0.97
Salivary gland neoplasms as a late consequence of head and neck irradiation. Ann Intern Med (1977) 0.97
Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. N Engl J Med (1985) 0.97
Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab (1984) 0.96
Cardiac papillary fibroelastoma: a source of coronary artery emboli and myocardial infarction. Henry Ford Hosp Med J (1984) 0.95
Metabolic clearance and secretion rates of human prolactin in normal subjects and in patients with chronic renal failure. J Clin Endocrinol Metab (1980) 0.95
125I-labeled fasciculin 2: a new tool for quantitation of acetylcholinesterase densities at synaptic sites by EM-autoradiography. J Neurosci Methods (1998) 0.95
Primary tumors of the pericardium and heart. Cardiovasc Clin (1973) 0.95
Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis. Am J Pathol (1992) 0.95
Cloning and characterization of mouse growth hormone-releasing hormone (GRH) complementary DNA: increased GRH messenger RNA levels in the growth hormone-deficient lit/lit mouse. Mol Endocrinol (1989) 0.94
Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells. Br J Cancer (2003) 0.94
The thyroid scintigram. II. The cold nodule. Radiology (1965) 0.94
Role of prostaglandin in thyrotropin action on thyroid. Endocrinology (1972) 0.94
Incidence, prevalence and characteristics of radiation-induced thyroid tumors. Am J Med (1978) 0.93
Plasma thyroglobulin in detecting thyroid carcinoma after childhood head and neck irradiation. Ann Intern Med (1977) 0.93
Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man. J Clin Invest (1984) 0.93
Breast lesions: differential diagnosis using digital subtraction angiography. Radiology (1986) 0.92
Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid. J Clin Endocrinol Metab (1994) 0.92
Growth hormone releasing action of a Pseudomonas endotoxin (piromen). Metabolism (1967) 0.92
Cortisol induction of growth hormone synthesis in a clonal line of rat pituitary tumor cells in culture. Science (1969) 0.92
Primary polydipsia. Syndrome of inappropriate thirst. Arch Intern Med (1983) 0.92
Treponemal antibodies in non-syphilitic, positive anti-nuclear factor sera. J Invest Dermatol (1966) 0.91
Idiopathic degeneration of the aortic valve: a common cause of isolated aortic regurgitation. J Am Coll Cardiol (1985) 0.91
Congenital polycystic tumor of the atrioventricular node (endodermal heterotopia, mesothelioma): a histogenetic appraisal with evidence for its endodermal origin. Hum Pathol (1987) 0.91
Plasma growth hormone responses and growth retardation of hypothyroidism. Am J Dis Child (1968) 0.91
p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation. Oncogene (2000) 0.91
Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. J Clin Invest (1978) 0.91
Effects of growth hormone excess and deficiency on hypothalamic somatostatin content and release and on tissue somatostatin distribution. Endocrinology (1981) 0.91
Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions. Arch Dermatol (1970) 0.91
Addison's Disease in half-siblings. Henry Ford Hosp Med J (1968) 0.91
Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation. Ann Intern Med (1980) 0.91
Use of protein A--containing Staphylococcus aureus as an immunoadsorbent in radioimmunoassays to separate antibody-bound from free antigen. J Lab Clin Med (1979) 0.90
Immunologic and biologic properties of antibodies to a glucagon-serum albumin polymer. Endocrinology (1970) 0.90
Clinical neuropharmacology of hypothalamic releasing factors. N Engl J Med (1972) 0.90
Cerebral gigantism. Pediatrics (1968) 0.90
Benign mixed tumor of the trachea. Cancer (1979) 0.90
Diagnosis and treatment of acromegaly complications. J Endocrinol Invest (2003) 0.90
Pathologic features of suicidal deaths caused by explosives. Am J Forensic Med Pathol (2003) 0.89
"Large" growth hormone: ribonucleic acid-associated precursor of other growth hormone forms in rat pituitary. Endocrinology (1974) 0.89
Rhabdomyosarcoma: an ultrastructural appraisal. Pathol Annu (1972) 0.89
Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats. J Neuroendocrinol (1999) 0.89
Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease. Int J Immunogenet (2012) 0.89
Effect of caloric restriction on the glucose tolerance and plasma insulin of the sand rat. Metabolism (1967) 0.88
The immunofluorescent "band" test for lupus erythematosus. I. Morphologic variations of the band of localized immunoglobulins at the dermal-epidermal junction in lupus erythematosus. Arch Dermatol (1969) 0.88
Differential effects of neonatal and adult androgen exposure on the growth hormone secretory pattern in male rats. Endocrinology (1987) 0.88
Growth hormone-dependent regulation of pituitary GH secretagogue receptor (GHS-R) mRNA levels in the spontaneous dwarf Rat. Neuroendocrinology (1998) 0.88
Acute effects of human growth hormone on insulin secretion and glucose utilization in normal and growth hormone deficient subjects. J Clin Endocrinol Metab (1967) 0.88
Growth hormone enhances hepatic epidermal growth factor receptor concentration in mice. J Clin Invest (1988) 0.88
Central nervous system mediated inhibition of insulin secretion due to 2-deoxyglucose. Horm Metab Res (1973) 0.87
Congenital adrenal hypoplasia--an X-linked disease. J Med Genet (1970) 0.87
Diethylstilbestrol inhibits tumor growth and prolactin production in rat pituitary tumors. Am J Pathol (1985) 0.87
Measurement of growth hormone-releasing factor. Methods Enzymol (1986) 0.87
Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man. J Clin Endocrinol Metab (1984) 0.87